As of Apr 29
| -0.47 / -2.83%|
The 6 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 24.00, with a high estimate of 30.00 and a low estimate of 18.50. The median estimate represents a +48.88% increase from the last price of 16.12.
The current consensus among 8 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.